StockData
Talphera, Inc. logo

Talphera, Inc. (TLPH) stock

TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.80−0.06 (-6.98%)

Close on Nov 17, 2026Market cap $41.57MP/E –Yield –

Earnings

Talphera's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 22, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
– on a year earlier
EPS, Q3 FY2026
-$0.05
-$0.11 a year earlier
Latest guidance
Issued
Mar 23, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Talphera's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 22, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close––-$0.05Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026during market hours––-$0.06Release
Q1 FY2026ended Mar 31, 2026May 13, 2026during market hours––-$0.04Release
Q4 FY2025ended Dec 31, 2025Mar 23, 2026before the open––-$0.06Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025during market hours$1.00K–-$0.11Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours––-$0.10Release
Q1 FY2025ended Mar 31, 2025May 14, 2025during market hours$27.00K–-$0.10Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025during market hours––-$0.07Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024during market hours––-$0.13Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024during market hours––-$0.15Release
Q1 FY2024ended Mar 31, 2024May 14, 2024during market hours––-$0.16Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Talphera's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Cash operating expenses, or selling, general and administrative, and research and development expenses, excluding stock-based compensationnon-GAAPFY2026$17.00M – $18.00M–NewMar 23, 2026

Guidance history

Every forecast Talphera put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 23, 2026Cash operating expenses, or selling, general and administrative, and research and development expenses, excluding stock-based compensationFY2026$17.00M – $18.00MNew
Nov 12, 2025Cash operating expenses, or selling, general and administrative, and research and development expenses, excluding stock-based compensationFY2025$14.00M – $15.00MNew
Aug 14, 2025Cash operating expensesFY2025$16.00M – $17.00MLowered
May 14, 2025Cash operating expenses, or selling, general and administrative, and research and development expenses, excluding stock-based compensationFY2025$17.00M – $19.00MLowered
Mar 31, 2025Cash operating expensesFY2025$18.00M – $19.00MNew
Mar 10, 2022Annual capital expendituresFY2022$2.00MNew
Mar 10, 2022Annual debt serviceFY2022$10.00MNew
Mar 10, 2022combined R&D and SG&A expenseFY2022$9.00M – $10.00MNew
Mar 10, 2022combined R&D and SG&A expense excluding stock compensation and depreciationFY2022$8.00M – $9.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Talphera filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. News
  14. Results
  15. Update

See a number that looks wrong?